SCHEMBL19465225

SCHEMBL19465225

Cc1ccc(C(C)Cc2ccc(C(C)C)cc2C#N)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ ACHE P22303 1/20 0.34
▸ CYP1A2 P05177 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ADRB2 P07550 1/20 0.33
▸ ADRB1 P08588 1/20 0.33
▸ ADRB3 P13945 1/20 0.33
▸ XDH P47989 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ CYP2A6 P11509 1/20 0.32
▸ AR P10275 2/20 0.32
▸ STAT3 P40763 1/20 0.32
▸ TRPA1 O75762 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22252057 0.87 TACR1 (0.33) CYP1A2CYP3A4TSHRMAPK1ADRB2
SCHEMBL20932914 0.84 CYP2A6 (0.43) PDE3BPDE3AACHEESR1ESR2
SCHEMBL20178542 0.82 CYP1A2 (0.37) CYP1A2CYP3A4TSHRMAPK1ADRB2
SCHEMBL25786867 0.77 MCL1 (0.40) ACHECYP1A2CYP3A4TSHRMAPK1
SCHEMBL17639914 0.76 CYP1A2 (0.37) CYP1A2CYP3A4TSHRMAPK1ADRB2
SCHEMBL17639917 0.76 ADRB2 (0.40) CYP1A2CYP3A4TSHRMAPK1ADRB2
SCHEMBL22861975 0.74 S1PR1 (0.39) PDE3BPDE3AALDH1A1CYP2A6
SCHEMBL23370929 0.74 CACNA1H (0.37) CYP1A2CYP3A4TSHRMAPK1ADRB2
SCHEMBL24246909 0.72 CYP2A6 (0.34) CYP1A2CYP3A4TSHRMAPK1ADRB2
SCHEMBL5177002 0.71 LMNA (0.52) ACHECYP1A2CYP3A4TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790210-B2 N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors ARRAY BIOPHARMA INC. (US) 2017-10-17 — — US disclosed
Send feedback